What Is Script Botanicals? Ingredients, Formats & What to Know

Script — listed at retail as Script Botanicals, and on its best-known line as Script x Maui Labs — is a brand selling chewable cat's claw tablets built around what its listings describe as a proprietary indole alkaloid blend derived from Uncaria tomentosa extract. Like most brands in this corner of the botanical shelf, it markets itself as kratom-free.

This guide walks through what Script publishes: per-tablet strength, the pack configurations it ships in, its flavor range, and what a "proprietary indole alkaloid blend" does and does not tell a buyer. Everything here comes from published retail and distributor specifications. Where we could not verify a figure, we say so rather than fill the gap. We sell cat's claw products ourselves — nothing below is an allegation against Script, which is an operating brand in a legal retail category.

The Plant Underneath

Cat's claw is the common name for Uncaria tomentosa, a woody climbing vine native to the Amazon basin and tropical regions of Central and South America. The name comes from the pair of curved, thorn-like hooks at its leaf nodes, which the vine uses to climb and which look like a cat's claws.

The plant naturally contains indole and oxindole alkaloids as well as polyphenols. That alkaloid class is the reason Script's listings use the phrase "indole alkaloid" — it is describing a family of compounds that occurs in the source plant, not a single isolated substance. Indole alkaloids are an enormous and chemically diverse group found across many unrelated plant families, so the term identifies a structural class rather than a specific molecule.

Cat's claw has a long history of traditional use among Indigenous peoples of the Amazon. That is historical and cultural background only, not evidence of any effect. It is also worth noting that several unrelated plants share the "cat's claw" common name, so the Latin binomial is the reliable identifier. Our background piece is at what is cat's claw.

What Script Sells

Script's products are chewable pressed tablets. The consistent published figure across retailers is 100mg per tablet, with the pack total varying by configuration.

The line most widely stocked is Paradise Blend, a collaboration marketed as Script x Maui Labs. It appears in two main retail configurations: a 2-count sachet totaling 200mg, and a 4-count pack totaling 400mg. Distributor listings also reference a 15-pack counter display of the 2-count sachets — a merchandising unit rather than a separate product.

This dual configuration is the likely origin of a common point of confusion. Script tablets are frequently searched for as "200mg tablets," but the 200mg figure is the two-tablet sachet total. The tablet itself is 100mg. Both numbers are accurate; they measure different things.

Published Specifications

Flavor availability rotates. Not every flavor appears at every retailer, and some listings show only a subset as selectable even when the description mentions the full range. We were not able to verify a complete inactive-ingredient panel, a standardization ratio for the extract, or a manufacturing location from public listings, so none of those are stated here.

What "Proprietary Blend" Actually Means

This is the part of Script's label worth spending time on, because it is a structural feature of the product rather than a detail.

A proprietary blend is a formulation whose total mass is disclosed but whose internal composition is not broken out component by component. When a listing says a 100mg tablet contains a proprietary indole alkaloid blend, the 100mg is the blend mass. How that mass divides among individual alkaloids, and what proportion is alkaloid versus other extract material, is not disclosed.

This is a legitimate and common industry practice — it protects formulation work from being copied. But it has a real consequence for buyers: you cannot compare a proprietary blend figure to a single-compound figure from another product. They are not the same kind of number. One measures a mixture; the other measures an isolated substance.

Practical implications:

• Blend mass is not potency. A larger blend figure does not necessarily mean more of any particular constituent than a smaller one from a different formulation.
• Cross-brand math does not work. Two 100mg proprietary blends from different brands may have entirely different internal compositions.
• Extract weight and alkaloid content are different measurements. Unless a standardization ratio is published — for example, an extract standardized to a stated percentage of a named constituent — a milligram figure is a weight, not a concentration.
• Documentation closes the gap. A certificate of analysis for the specific batch is what turns label text into something checkable. That is the standard we hold ourselves to at our COA page, and it is a reasonable thing to ask of any brand.

Kratom-Free Positioning and the 2026 Regulatory Picture

Script's listings state that the product contains no kratom and no 7-hydroxy. That positioning is near-universal among cat's-claw brands at the moment, and there is a dated reason for it.

On July 1, 2026, the Drug Enforcement Administration filed Notices of Intent to temporarily place 7-hydroxymitragynine above a specified threshold into Schedule I of the Controlled Substances Act, together with mitragynine pseudoindoxyl, MGM-15, and MGM-16. The notices published in the Federal Register on July 6, 2026. The temporary scheduling order publishes on or after August 5, 2026, becomes effective on publication, and runs two years while the agency can pursue permanent scheduling. The thresholds are 0.05% for leaf material, and 0.05% or 1mg per article for extracts, concentrates, and pressed pills. The announcement is at dea.gov.

The phrase "per article" is what made the action concrete for the pressed-tablet category — a single tablet counts as an article. But the compounds named are alkaloids associated with Mitragyna speciosa. Uncaria tomentosa is a different plant in a different genus and does not contain them. A cat's-claw brand noting that its product is not kratom is describing its ingredient panel, not claiming an exemption from a rule that would otherwise reach it.

Two things worth holding separately here. First, the federal action applies by substance, concentration, and quantity — not by brand name or marketing category. Second, state law is its own layer and varies; nothing in this article is legal advice, and questions about a specific jurisdiction are for a qualified attorney. Our walkthrough of the federal action is at is 7-OH banned.

Where Script Sits in the Category

Cat's claw brands have converged on a similar physical product — a flavored chewable tablet in a small count — but diverge in how they describe what is inside.

Script represents the proprietary-blend approach: a single named botanical source, with the active described as a blend whose components are not itemized. Other brands take a single-botanical approach and simply state an extract weight. Others build multi-plant formulas naming two or three botanicals. Others still bundle the botanical into a branded complex alongside vitamins or other compounds.

The trade-off is consistent across the category. More disclosure means more to verify from the outside; less disclosure means more formulation privacy for the brand. Neither is a red flag on its own. What separates products in practice is whether independent lab documentation exists for the batch in hand, and whether the brand publishes it without being asked.

The 100mg per-tablet figure does put Script at the lower end of published per-tablet strengths in this category, where figures from 75mg to 200mg per tablet appear across brands. Because those numbers describe different formulations — some single-botanical extract weights, some multi-plant blends, some proprietary complexes — ranking them against each other is not as informative as it looks. If you want to see how the category compares side by side, our own line and documentation are in the cat's claw collection, and the botanical background is at what is cat's claw.

Frequently Asked Questions

Is Script 100mg or 200mg per tablet?

Published listings state 100mg per tablet. The 200mg figure that appears in many product titles is the total for a 2-count sachet. A 4-count pack is listed at 400mg total on the same 100mg-per-tablet basis.

What is Paradise Blend?

Paradise Blend is Script's most widely stocked line, marketed as a collaboration between Script Botanicals and Maui Labs. It is the cat's claw chewable tablet product described throughout this article.

What does "proprietary indole alkaloid blend" mean?

It means the active portion is a mixture derived from Uncaria tomentosa extract whose total mass is stated but whose individual components are not itemized. Indole alkaloids are a broad structural class of compounds found in many plants, including cat's claw. The phrase names a category of constituent, not one specific substance.

Does Script contain kratom or 7-OH?

The brand's listings state the product contains no kratom and no 7-hydroxy. Uncaria tomentosa is botanically unrelated to Mitragyna speciosa and does not naturally contain mitragynine or 7-hydroxymitragynine. Batch-specific third-party lab documentation is what makes such a statement independently verifiable.

What flavors are available?

Flavors reported across retail listings include Sour Apple, Sweet Citrus, Peach Sherbet, and Berry Punch. Availability rotates, and individual retailers typically stock only some of the range at any given time.

These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For adults 21+. Consult a qualified healthcare professional before use.